Perspective Therapeutics (CATX) Non-Current Assets (2016 - 2026)

Perspective Therapeutics' Non-Current Assets history spans 16 years, with the latest figure at $135.4 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 19.2% to $135.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $485.1 million, a 11.21% increase, with the full-year FY2025 number at $118.6 million, up 7.86% from a year prior.
  • Non-Current Assets hit $135.4 million in Q1 2026 for Perspective Therapeutics, up from $118.6 million in the prior quarter.
  • Over the last five years, Non-Current Assets for CATX hit a ceiling of $135.4 million in Q1 2026 and a floor of $3.4 million in Q1 2022.
  • Historically, Non-Current Assets has averaged $80.9 million across 5 years, with a median of $90.1 million in 2024.
  • Biggest five-year swings in Non-Current Assets: soared 2504.44% in 2023 and later dropped 3.85% in 2025.
  • Tracing CATX's Non-Current Assets over 5 years: stood at $4.9 million in 2022, then surged by 1562.31% to $81.1 million in 2023, then surged by 35.64% to $109.9 million in 2024, then rose by 7.86% to $118.6 million in 2025, then increased by 14.2% to $135.4 million in 2026.
  • Business Quant data shows Non-Current Assets for CATX at $135.4 million in Q1 2026, $118.6 million in Q4 2025, and $116.3 million in Q3 2025.